We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Labcyte Expands Acoustic Dispensing and Launches into New Markets
Product News

Labcyte Expands Acoustic Dispensing and Launches into New Markets

Labcyte Expands Acoustic Dispensing and Launches into New Markets
Product News

Labcyte Expands Acoustic Dispensing and Launches into New Markets


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Labcyte Expands Acoustic Dispensing and Launches into New Markets"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Labcyte has introduced two pre-calibrated liquid class packages for use with its Echo® acoustic dispensers and POD™ 810 plate assemblers, which move liquids with sound. This expanded capability will allow its high throughput screening customers to not only transfer compounds in DMSO, but enables the transfer of a wide range of liquids necessary to assemble miniaturized assays for biochemical and cell-based screening.

In addition the Echo platform can now address growing applications in Genomics and Proteomics such as siRNA screening, real-time PCR genotyping, and protein-based arrays.

“Labcyte has revolutionized liquid handling with multiple systems in all of the top 10 pharmaceutical companies,” said Mark Fischer-Colbrie, Chief Executive Officer and President of Labcyte. “We are now positioned to offer the same guaranteed level of precision and accuracy to a brand new set of customers who are looking to miniaturize their assays while getting better results and cost savings due to the Echo platform’s ‘touchless’ dispensing capability.”

“The Echo Screening Package and the Echo Omics Package allow customers to change applications, on the fly, without the need for custom calibrations,” said Stephen Bates, Sr. Vice President of Sales, Marketing and Support.

Bates continued, “Our users can now run a wide range of applications where they need to transfer compounds in DMSO, or aqueous solutions that contain DNA, RNA or proteins, surfactants, and buffers. All of this is done without the use of disposable tips leading to better results and lower costs.”

Labcyte also introduced a 1536-well source plate which meets user requests for lower dead volume and increased working volume. The new 1536LDV plate cuts dead volume in half, increases the working volume by 12.5% and provides greater throughput compared to other 1536-well source plates, Labcyte claims.
Advertisement